Vaginal Hysterectomy



Vaginal Hysterectomy


Cecile A. Unger



General Principles



Preoperative Planning



  • The preoperative health assessment for any hysterectomy includes a complete history and physical examination. There is no routinely recommended imaging, cardiopulmonary testing, or laboratory tests. This type of testing is ordered for patients based on their medical comorbidities. Many hospitals have their own requirements for preoperative assessments, which are often based on the patient’s age in combination with their medical comorbidities and frailty.


  • A normal Papanicolaou (Pap) smear should be documented before hysterectomy. In patients who are at risk for endometrial cancer, endometrial sampling should also be obtained. If cancer or an adnexal mass or cyst is suspected, a transvaginal ultrasound is necessary.


  • Careful review of a patient’s medication list is important before performing a hysterectomy. Because of the increased risk of bleeding due their antiplatelet effects, all nonsteroidal anti-inflammatory drugs and aspirin should be stopped at least 7 days before surgery. Multivitamins containing vitamin E should also be discontinued 10 to 14 days before surgery. Because of the increased risk of venous thromboembolic events, oral contraceptive pills and hormone replacement therapies should ideally be stopped 4 to 6 weeks before surgery. This may be challenging in women who are on hormone therapies for abnormal bleeding, but cessation should be considered.


  • Before proceeding with hysterectomy, assessment of a patient’s risk for intra- or postoperative anemia and need for autologous blood products is necessary. This is especially important for patients with abnormal uterine bleeding and baseline anemia. These patients should also be evaluated for preoperative iron supplementation or transfusion.


  • Informed consent should be obtained in the office. Patients should be well informed of the risks and benefits of the procedure, as well as the alternatives to hysterectomy. Most importantly, confirmation of completion of childbearing must be done.


  • Prior to surgery, a pregnancy test is necessary in all patients of reproductive age.


  • Hysterectomy is a clean-contaminated procedure, and prophylactic intravenous antibiotics should be ordered, to be administered within 60 minutes of incision time. First- or second-generation cephalosporins are first-line antibiotics.


  • All patients undergoing hysterectomy are considered “moderate risk” and require venous thromboembolism prophylaxis. In most patients, either low-dose unfractionated heparin, low–molecular-weight heparin, or intermittent pneumatic compression devices are recommended. In higher-risk patients, dual prophylaxis, and in some cases, postoperative prophylaxis may be necessary.


  • Route of hysterectomy is dependent on the following factors: vaginal caliber and accessibility to the uterus, uterine size and shape, uterine mobility, cancer and extrauterine disease, surgeon skillset, available support facilities, and surgeon and patient preference.


  • A thorough bimanual examination is necessary prior to deciding on route of hysterectomy. Care should be taken to note the following factors to help determine the degree of difficulty that will be present in performing the procedure: the size, mobility, and descent of the uterus; the size and shape of the bony pelvis (a pubic arch of less than 90 degrees may preclude a vaginal hysterectomy whereas a wide angle will facilitate the approach); the caliber of the introitus and the vagina.


Surgical Management



  • According to the American College of Obstetricians and Gynecologists (ACOG),1 vaginal hysterectomy is the safest and most cost-effective method to remove the uterus for noncancerous reasons. In general, based on current data, vaginal hysterectomy is associated with better outcomes and fewer complications.


  • There are few absolute contraindications to the vaginal approach for hysterectomy; however, there are factors that generally preclude this approach, including (1) the suspicion of malignancy; (2) the presence of known extrauterine disease or adnexal disease; (3) a narrow pubic arch (<90 degrees); (4) a narrow vagina (narrower than 2 fingerbreadths, especially at the apex); and (5) a fixed, immobile uterus. In the absence of one of these factors, vaginal hysterectomy should be the approach of choice whenever feasible given its well-documented advantages.


  • There are some conditions and patient-specific characteristics that can make vaginal hysterectomy technically challenging. These factors are not contraindications to vaginal hysterectomy, but should be identified preoperatively and anticipated at the time of surgery.


  • These conditions include the enlarged or undescended uterus, previous cesarean sections, and uterine prolapse. These factors should be taken into consideration during surgical planning, and while they may make the procedure more challenging, can be overcome with a few helpful pearls that we will review in this chapter.


Positioning



  • Patients are positioned in dorsal lithotomy position using either candy cane stirrups (Fig. 8.5.1), or yellow fin stirrups (Fig. 8.5.2). Patients should be positioned so that the edge of the buttocks is at the edge of the surgical table. Care is taken
    not to hyperflex or extend the legs in order to avoid postoperative neuropathies. Foam can be used to pad the bony prominences of the limbs, and also to fill dead space in the stirrups. The arms can be left out at the sides, and are positioned in anatomic position with care taken to not hyperextend the limbs to avoid brachial plexus injuries.






    Figure 8.5.1. Dorsal lithotomy positioning using candy cane stirrups.






    Figure 8.5.2. Dorsal lithotomy positioning using yellowfin stirrups.


Approach



  • The procedure is performed transvaginally.
















Oct 13, 2018 | Posted by in GYNECOLOGY | Comments Off on Vaginal Hysterectomy

Full access? Get Clinical Tree

Get Clinical Tree app for offline access